CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
| Revenue (Most Recent Fiscal Year) | $7.01M |
| Net Income (Most Recent Fiscal Year) | $-3.08M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.49 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.39 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -70.47% |
| Net Margin (Trailing 12 Months) | -70.47% |
| Return on Equity (Trailing 12 Months) | -60.19% |
| Return on Assets (Trailing 12 Months) | -28.29% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.84 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.24 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.19 |
| Inventory Turnover (Trailing 12 Months) | 2.25 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.70 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 17.16M |
| Free Float | 8.57M |
| Market Capitalization | $3.09M |
| Average Volume (Last 20 Days) | 0.11M |
| Beta (Past 60 Months) | 0.72 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 46.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |